{"id":5043,"date":"2022-02-10T12:31:53","date_gmt":"2022-02-10T11:31:53","guid":{"rendered":"https:\/\/copolad.ole.agency\/observatories-on-f1-drugs\/"},"modified":"2024-05-09T11:27:44","modified_gmt":"2024-05-09T09:27:44","slug":"observatories-on-f1-drugs","status":"publish","type":"page","link":"https:\/\/copolad.eu\/en\/observatories-on-f1-drugs\/","title":{"rendered":"Observatories on Drugs"},"content":{"rendered":"

[vc_row][vc_column][vc_empty_space height=”10px”][\/vc_column][\/vc_row][vc_row vc_row_background=”” el_class=”.jeg_sidebar_left”][vc_column width=”2\/3″][vc_custom_heading text=”Observatories on Drugs” font_container=”tag:h1|font_size:48px|text_align:left|color:%23000000|line_height:72px” google_fonts=”font_family:Open%20Sans%3A300%2C300italic%2Cregular%2Citalic%2C600%2C600italic%2C700%2C700italic%2C800%2C800italic|font_style:700%20bold%20regular%3A700%3Anormal” css=”.vc_custom_1639382317247{margin-top: 0px !important;}”][vc_single_image image=”4048″ img_size=”large”][vc_column_text]Effective policies can only be based on\u00a0the availability of accurate<\/strong>\u00a0and comparable indicators on drug use, their impact on health, as well as market-related indicators. in previous phases,\u00a0COPOLAD III will strengthen the National Drug Observatories (NDOs)<\/strong>\u00a0o guarantee a solid National Drug Information System in each partner country, not only to collect quality data, but also to supervise, analyse and interpret the collected information, monitoring and evaluating the impacts of national drug policies in the different dimensions of sustainable development, with a gender, differential and rights approach.<\/p>\n

COPOLAD III has direct participation through a grant from the\u00a0European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)<\/strong>\u00a0as a collaborating partner.[\/vc_column_text][vc_custom_heading text=”Lines of action” font_container=”tag:h2|font_size:20px|text_align:left|color:%2315110d|line_height:28px” google_fonts=”font_family:Open%20Sans%3A300%2C300italic%2Cregular%2Citalic%2C600%2C600italic%2C700%2C700italic%2C800%2C800italic|font_style:700%20bold%20regular%3A700%3Anormal”][vc_tta_accordion color=”white” c_icon=”chevron” c_position=”right” active_section=”99″ collapsible_all=”true” el_class=”acordeon”][vc_tta_section title=”1.1 Strategic support for strengthening national systems and regional networks for scientific research on drugs.” tab_id=”1641370837562-b5bb89b5-c57c”][vc_column_text css_animation=”none” el_class=”actividades”]<\/p>\n

Activities<\/h4>\n

1.1.1 Holding a regional workshop on the development and strengthening of national scientific research systems on drugs<\/p>\n

1.1.2 Technical assistance, distance mentoring for the formation and implementation of scientific advisory committees for observatories, networks of researchers and research centres, national drug research funds, national drug research agendas.<\/p>\n

1.1.3 Development of an EU-LAC bi-regional conference (face-to-face in Bogota, Colombia) on research on drug policy and sustainable development.<\/p>\n

[\/vc_column_text][\/vc_tta_section][vc_tta_section title=”1.2 Improvement of the analysis and incidence capacity of the National Observatories on Drugs.” tab_id=”1641370837603-58ef32bc-9fab”][vc_column_text css_animation=”none” el_class=”actividades”]<\/p>\n

Activities<\/h4>\n

1.2.1 Preparation and delivery of 2 online seminars: innovative evaluations<\/p>\n

\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a01.2.2.\u00a0 Ad hoc technical support to strengthen the technical capacity of NDOs and networking, including visits to LAC and Europe<\/p>\n

 [\/vc_column_text][\/vc_tta_section][vc_tta_section title=”1.3 Incorporation of the differential and rights approach in the information and investigation systems of the NDOs.” tab_id=”1641371159705-4ed73179-1f31″][vc_column_text css_animation=”none” el_class=”actividades”]<\/p>\n

Activities<\/h4>\n

1.3.1 Preparation of materials, reference documents and delivery of webinars:<\/p>\n

[\/vc_column_text][vc_row_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

1.3.1.1 International guidelines on human rights and drug policies<\/p>\n

[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

1.3.1.2 Incorporation of a differential approach and rights in information systems<\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_column_text css_animation=”none” el_class=”actividades”]<\/p>\n

1.3.2 Holding two virtual regional workshops to support the design and implementation of national roadmaps for the incorporation of differential and rights approaches in the information and research systems of the Observatories .<\/p>\n

[\/vc_column_text][\/vc_tta_section][vc_tta_section title=”1.4 Development and strengthening of drug policy monitoring and evaluation systems.” tab_id=”1641371245534-43417bea-d94e”][vc_column_text css_animation=”none” el_class=”actividades”]<\/p>\n

Activities<\/h4>\n

1.4.1 Holding two workshops to develop a methodology for evaluating the impacts of national drug policies on the different dimensions of sustainable development.<\/p>\n

1.4.2 Technical assistance for preparing a methodological guide for the evaluation of the impacts of national drug policies on sustainable development.<\/p>\n

1.4.3 Technical assistance for the development of a national pilot study on the impact of drug policies in an LAC country on the different dimensions of sustainable development.<\/p>\n

1.4.4 Holding of a bi-regional webinar to present the methodology and results of research on the impact of drugs on development<\/p>\n

1.4.5 Study visits on cannabis policy evaluation<\/p>\n

1.4.6 Seminars on cannabis policy evaluation<\/p>\n

1.4.7 Organisation of a bi-regional seminar on the evaluation of cannabis policies<\/p>\n

1.4.8 Three studies focused on national cannabis policies.<\/p>\n

1.4.9 Technical assistance to develop a cannabis policy evaluation toolkit<\/p>\n

1.4.10 Creation of a virtual community of practice\/learning on cannabis policy evaluation.<\/p>\n

[\/vc_column_text][\/vc_tta_section][vc_tta_section title=”1.5 Development and strengthening of national Early Warning Systems.” tab_id=”1641371377733-f4a65417-8e6d”][vc_column_text css_animation=”none” el_class=”actividades”]<\/p>\n

Activities<\/h4>\n

1.5.1 Participation at the international conference on new psychoactive substances and meeting with Panamanian authorities.<\/p>\n

\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 1.5.2 Direct technical assistance to strengthen existing early warning\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 systems.<\/p>\n

1.5.3 Translation of key EMCDDA publications on psychoactive\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0substances into Spanish.<\/p>\n

1.5.4 Participation in meetings organised by CELAC countries to strengthen the early warning system.[\/vc_column_text][\/vc_tta_section][vc_tta_section title=”1.6 Technical support for developing fundamental aspects of the National Drug Observatories (NDOs).” tab_id=”1641371428459-bf8d4229-a1d6″][vc_column_text css_animation=”none” el_class=”actividades”]<\/p>\n

Activities<\/h4>\n

1.6.1 Holding two meetings of NDO managers from Latin America and the Caribbean and Europe.<\/p>\n

1.6.2 Conducting a study visit to the observatories in Portugal and Spain.<\/p>\n

1.6.3 Technical support to NDOs (help-desk support) through an online tool.<\/p>\n

1.6.4 Implementation of a community of practice and learning that articulates demands and offers of support.<\/p>\n

1.6.5 Establishment of virtual sub-working groups.<\/p>\n

1.6.6 Mentoring by experts (South-South and triangular) to improve knowledge generation processes at the national level.<\/p>\n

[\/vc_column_text][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][vc_column width=”1\/3″ sticky_sidebar=”yes” set_as_sidebar=”yes”][vc_wp_custommenu nav_menu=”34″ el_class=”tab-style”][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_empty_space height=”10px”][\/vc_column][\/vc_row][vc_row vc_row_background=”” el_class=”.jeg_sidebar_left”][vc_column width=”2\/3″][vc_custom_heading text=”Observatories on Drugs” font_container=”tag:h1|font_size:48px|text_align:left|color:%23000000|line_height:72px” google_fonts=”font_family:Open%20Sans%3A300%2C300italic%2Cregular%2Citalic%2C600%2C600italic%2C700%2C700italic%2C800%2C800italic|font_style:700%20bold%20regular%3A700%3Anormal” css=”.vc_custom_1639382317247{margin-top: 0px !important;}”][vc_single_image image=”4048″ img_size=”large”][vc_column_text]Effective policies can only be based on\u00a0the availability of accurate\u00a0and comparable indicators on drug use, their impact on health, as well as market-related indicators. in previous phases,\u00a0COPOLAD III will strengthen the National Drug Observatories (NDOs)\u00a0o guarantee a solid National Drug Information […]<\/p>\n","protected":false},"author":9,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"courseId":0,"jnews_page_loop":{"enable_page_loop":"0","first_title":"Latest Post","second_title":"","header_type":"heading_6","header_background":"","header_text_color":"","layout":"right-sidebar","sidebar":"default-sidebar","second_sidebar":"default-sidebar","sticky_sidebar":"1","module":"3","boxed":"0","boxed_shadow":"0","box_shadow":"0","excerpt_length":"20","content_date":"default","date_custom":"Y\/m\/d","content_pagination":"nav_1","pagination_align":"center","show_navtext":"0","show_pageinfo":"0","post_offset":"0","posts_per_page":"5","include_post":"","exclude_post":"","include_category":"","exclude_category":"","include_author":"","include_tag":"","exclude_tag":"","sort_by":"latest"},"jnews_single_page":{"layout":"no-sidebar","sidebar":"default-sidebar","second_sidebar":"default-sidebar","sticky_sidebar":"1","show_post_featured":"1","show_post_meta":"0","share_position":"top","share_color":"share-monocrhome"},"jnews_social_meta":{"fb_title":"","fb_description":"","fb_image":"","twitter_title":"","twitter_description":"","twitter_image":""},"footnotes":""},"class_list":["post-5043","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/copolad.eu\/en\/wp-json\/wp\/v2\/pages\/5043"}],"collection":[{"href":"https:\/\/copolad.eu\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/copolad.eu\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/copolad.eu\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/copolad.eu\/en\/wp-json\/wp\/v2\/comments?post=5043"}],"version-history":[{"count":1,"href":"https:\/\/copolad.eu\/en\/wp-json\/wp\/v2\/pages\/5043\/revisions"}],"predecessor-version":[{"id":10604,"href":"https:\/\/copolad.eu\/en\/wp-json\/wp\/v2\/pages\/5043\/revisions\/10604"}],"wp:attachment":[{"href":"https:\/\/copolad.eu\/en\/wp-json\/wp\/v2\/media?parent=5043"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}